NCT06769646

SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 110,074 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is being carried out in 4 countries (France, Italy, Spain and the UK) to understand the clinical care pathway of population living with type 2 diabetes who also have evidence of chronic kidney disease. The primary objective is to describe the population with T2D and CKD in terms of demography, clinical characteristics and medication use by CKD stage.

Conditions

• Type 2 Diabetes Mellitus (T2D) and Chronic Kidney Disease (CKD)

Interventions

Type	Name	Description
OTHER	No tretament given	No treatment given

Timeline

• Start date: 2024-12-02
• Primary completion: 2025-01-06
• Completion: 2025-01-06
• First posted: 2025-01-10
• Last updated: 2025-03-27

Locations

1 site across 1 country: India